HIGHLIGHTS
- who: IgA nephropathy and colleagues from the Zhejiang University School of Medicine, China have published the research work: Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study, in the Journal: (JOURNAL)
- what: The authors aim to evaluate the efficacy and safety of low-dose CS combined with CTX or MMF in IgAN patients with renal insufficiency in a 10-year real-world cohort study. The study showed the incidence of severe pneumonia was 9.1% in the CS + MMF . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.